文献速递造血干细胞移植与细胞治疗

MAGIC生物标志物预测激素抵抗性急性GVHD的长期结局

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
PubMed 文献 · Blood · 2018-03-15

研究分析了MAGIC联盟17个中心507例急性GVHD患者系统治疗1周后的临床数据与血样,分为测试队列(n=236)和两个时间分离的验证队列(n=142和n=129)。先前验证的ST2和REG3α双标志物算法在三个队列中均将激素抵抗患者分为非复发死亡率和总生存率差异巨大的两组(P < .001)。生物标志物概率的AUC(0.82)显著优于激素反应(0.68,P = .004)和Minnesota风险(0.72,P = .005)。

要点

  • MAGIC生物标志物概率在激素抵抗性GVHD中预测长期结局优于临床标准。
  • 初始激素反应与4周反应、1年非复发死亡率和总生存率相关。
  • 生物标志物概率AUC 0.82显著高于激素反应0.68和Minnesota风险0.72。

核心结论

  • 系统治疗1周后生成的MAGIC生物标志物概率预测激素抵抗性GVHD的长期结局优于临床标准,应有助于制定更好的治疗策略。

研究设计与样本

  • 分析MAGIC联盟17个中心507例急性GVHD患者系统治疗1周后的临床数据和血样,分为测试队列(n=236)和两个时间分离的验证队列(n=142和n=129)。

主要发现

  • 初始系统激素反应与4周反应、1年非复发死亡率和总生存率相关。
  • 先前验证的ST2和REG3α双标志物算法在全部3个队列中均将激素抵抗患者分为非复发死亡率和总生存率差异巨大的两组(P < .001)。
  • 多因素分析中,高生物标志物概率、激素抵抗和GVHD严重程度(Minnesota风险)均为非复发死亡率的显著预测因素。
  • 受试者工作特征曲线直接比较显示,生物标志物概率的曲线下面积(0.82)显著大于激素反应(0.68,P = .004)和Minnesota风险(0.72,P = .005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute graft-versus-host disease (GVHD) is treated with systemic corticosteroid immunosuppression. Clinical response after 1 week of therapy often guides further treatment decisions, but long-term outcomes vary widely among centers, and more accurate predictive tests are urgently needed. We analyzed clinical data and blood samples taken 1 week after systemic treatment of GVHD from 507 patients from 17 centers of the Mount Sinai Acute GVHD International Consortium (MAGIC), dividing them into a test cohort (n = 236) and 2 validation cohorts separated in time (n = 142 and n = 129). Initial response to systemic steroids correlated with response at 4 weeks, 1-year nonrelapse mortality (NRM), and overall survival (OS). A previously validated algorithm of 2 MAGIC biomarkers (ST2 and REG3α) consistently separated steroid-resistant patients into 2 groups with dramatically different NRM and OS (P < .001 for all 3 cohorts). High biomarker probability, resistance to steroids, and GVHD severity (Minnesota risk) were all significant predictors of NRM in multivariate analysis. A direct comparison of receiver operating characteristic curves showed that the area under the curve for biomarker probability (0.82) was significantly greater than that for steroid response (0.68, P = .004) and for Minnesota risk (0.72, P = .005). In conclusion, MAGIC biomarker probabilities generated after 1 week of systemic treatment of GVHD predict long-term outcomes in steroid-resistant GVHD better than clinical criteria and should prove useful in developing better treatment strategies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Major-Monfried H, Renteria AS, Pawarode A, et al. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood. 2018. PMID: 29545329. doi:10.1182/blood-2018-01-822957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。